Looking for a modern electronic clinical outcome assessment (eCOA) solution to streamline your clinical trials and improve the Tender Swollen Joint Count (TSJC) user experience? Traditional assessments are cumbersome and can lead to clinical data inaccuracies. YPrime’s all-new TSJC assessment tackles these challenges head-on, delivering: 

Streamlined TSJC eCOA Data Collection Delivers Enhanced Efficiency 
Our intuitive TSJC assessment design simplifies clinical data entry, minimizing errors and missing data across therapeutic areas. The unique homunculus body map allows for quick and easy joint selection, saving valuable time during tender swollen joint assessments. Pre-populated reasons for non-evaluable joints further ensure data consistency and reduce ambiguity. 

Superior TSJC Data Quality and Regulatory Compliance 
Eliminate manual errors and expedite data analysis with instant tender and swollen joint counts displayed directly on the screen. Minimize inaccuracies with a two-step review system, fostering regulatory compliance. Detailed audit trails maintain complete transparency with a record of all edits and changes, facilitating seamless audits.

YPrime’s industry-leading eCOA platform is configurable enabling up to 30% faster launch times with easier protocol amendment implementation.  User-friendly design drives participant engagement and high-quality data collection, while quality experts proactively identify issues and take preventative measures, delivering quality standards 50% above the industry average. 

Download our Tender Swollen Joint Count eCOA Fact Sheet today, or email marketing@yprime.com to get started.